Holen Sie sich die Stockscreener-App
4.025
0.88%
0.035
Schlusskurs vom Vortag:
$3.99
Offen:
$4
24-Stunden-Volumen:
3,732
Relative Volume:
0.00
Marktkapitalisierung:
$98.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.12%
1M Leistung:
-12.50%
6M Leistung:
+50.75%
1J Leistung:
+0.37%
1-Tages-Spanne:
$3.89
$4.03
1-Wochen-Bereich:
$3.62
$4.11
52-Wochen-Spanne:
$1.47
$7.36
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Firmenname
Artiva Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 267-4467
Adresse
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
4.025 | 97.93M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.80 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.16 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
849.42 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.42 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
349.67 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Eingeleitet | Jefferies | Buy |
| 2024-08-13 | Eingeleitet | Needham | Buy |
| 2024-08-13 | Eingeleitet | TD Cowen | Buy |
| 2024-08-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Artiva Biotherapeutics Inc Aktie (ARTV) Neueste Nachrichten
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $19.00 Average PT from Brokerages - Defense World
ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics executes RSU exchange for employees - MSN
Trading Action: Is Artiva Biotherapeutics Inc stock a good pick for beginnersJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Hedge Fund Bets: Is CFRPRB stock heavily shortedTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Decline in Short Interest - MarketBeat
Pharma News: Can AGMH outperform under higher oil pricesTrade Exit Report & Technical Entry and Exit Tips - baoquankhu1.vn
Brokers Set Expectations for ARTV FY2030 Earnings - Defense World
Income Plays: Is Artiva Biotherapeutics Inc.’s ROE strong enoughJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - mfd.ru
Update Report: Can Artiva Biotherapeutics Inc. outperform in the next rallyJuly 2025 Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Undervalued Penny Stocks To Consider In January 2026 - simplywall.st
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY) - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Contin - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at - GlobeNewswire
Take Profit: Is Artiva Biotherapeutics Inc part of any ETF2025 Price Targets & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Catalysts: How do insiders feel about Artiva Biotherapeutics IncJuly 2025 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Take Profit: Can Artiva Biotherapeutics Inc outperform in the next rallyWeekly Market Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Wall Street Recap: Is AppTech Payments Corp Equity Warrant attractive for institutional investorsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Trend Recap: Will Artiva Biotherapeutics Inc outperform its industry peers2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Artiva Biotherapeutics Stock: Upcoming Data Presentations In Focus (NASDAQ:ARTV) - Seeking Alpha
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Growth in Short Interest - MarketBeat
Published on: 2026-01-14 12:03:58 - baoquankhu1.vn
Quarterly Trades: Will Artiva Biotherapeutics Inc. stock gain from lower inflationWeekly Profit Recap & AI Powered Trade Plan Recommendations - Bộ Nội Vụ
Valuation Update: Can Pineapple Financial Inc be recession proofQuarterly Investment Review & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Published on: 2026-01-14 05:34:55 - baoquankhu1.vn
Sjogren’s Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics - Barchart.com
Bearish Setup: Will EWCZ stock benefit from green energy trends2025 Price Targets & Accurate Entry and Exit Point Alerts - Bộ Nội Vụ
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN
Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Review & Low Drawdown Investment Strategies - ulpravda.ru
How Artiva Biotherapeutics Inc. stock performs in weak economyQuarterly Market Summary & Technical Entry and Exit Tips - Улправда
Is Artiva Biotherapeutics Inc. stock oversold or undervaluedQuarterly Risk Review & Growth Focused Investment Plans - ulpravda.ru
Is Artiva Biotherapeutics Inc. stock a good choice for value investorsOil Prices & Stepwise Swing Trade Plans - Улправда
How Artiva Biotherapeutics Inc. stock performs in high volatility marketsJuly 2025 Sentiment & Proven Capital Preservation Methods - Улправда
NanoSyrinx Appoints New CEO to Advance Nanosyringe Technology - Intellectia AI
Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3% – Should You Buy? - Defense World
Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3%Should You Buy? - MarketBeat
Artiva Biotherapeutics expands board with industry veteran - MSN
Genelux Corporation Announces Appointment of Jason Litten as Chief Medical Officer, Effective January 2, 2026 - marketscreener.com
New medical chief to guide late-stage trials for cancer immunotherapy - Stock Titan
Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO’s Latest Insider Share Sale - Yahoo Finance
Will Artiva Biotherapeutics Inc. stock deliver long term returnsMarket Risk Summary & Reliable Entry Point Alerts - Улправда
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - MSN
Is Artiva Biotherapeutics Inc. stock undervalued vs historical averagesJuly 2025 PreEarnings & Technical Pattern Based Signals - DonanımHaber
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) dropped from NASDAQ Biotechnology Index - marketscreener.com
CEO Moves: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Big Picture & High Accuracy Swing Entry Alerts - Улправда
Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
Resistance Check: Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Safe Entry Trade Signal Reports - Улправда
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics CEO sells $19,122 in stock By Investing.com - Investing.com Nigeria
Finanzdaten der Artiva Biotherapeutics Inc-Aktie (ARTV)
Es liegen keine Finanzdaten für Artiva Biotherapeutics Inc (ARTV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):